Catalyst Wire Dossier Catalyst Wire Dossier

FURESTEM-RA Inj.

unknown · Kang Stem Biotech Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FURESTEM-RA Inj., covering 2022-10-10 to 2022-10-10. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis [Phase 1, Phase 2]

See pricing